Vaccine Trial Insights
A double blind trial ensures that neither participants nor researchers know who receives the vaccine, maintaining objectivity in the study. Researchers aim for a statistical confidence with 164 COVID cases, and preliminary results indicate over 90% efficacy seven days post-second dose. However, concerns arise regarding the virus's incubation period and whether the observation window is sufficient to capture all relevant cases.In this clip
From this podcast
Short Wave
The COVID-19 Vaccine Trial Results: What They Mean, What Comes Next
Related Questions